Señales en vivo de EMD.AX | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 jul 2024 @ 02:10):
Our systems believe the stock currently is undervalued by 4.28% compare to its pairs and should correct upwards.

Stats
Volumen de hoy	133 877
Volumen promedio	364 239
Capitalización de mercado	18.81M
EPS	$-0.0324 ( Q2 \| 2023-12-31 )
Próxima fecha de ganancias	( $0 ) 2024-07-28
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.150 (Sector) 0 (Industry) 0
ATR14	$0.00100 (2.08%)

AHX.AX -2.90%

ALC.AX 6.25%

ANN.AX -2.41%

AT1.AX 0.00%

AVR.AX 0.00%

CAJ.AX -4.76%

CAU.AX 0.00%

CDX.AX -7.14%

CGS.AX -0.89%

COH.AX -2.89%

CYC.AX -6.51%

EBO.AX -1.81%

EHE.AX 0.33%

EMD.AX 12.20%

EMV.AX -11.11%

FPH.AX -1.26%

HLA.AX 0.17%

HLS.AX -4.33%

HMD.AX 13.04%

IBX.AX -1.18%

IDX.AX -3.00%

IHL.AX -10.87%

IMR.AX -0.94%

IPD.AX -1.39%

M7T.AX -0.78%

MDR.AX -5.00%

MVF.AX -3.11%

MX1.AX -3.61%

NAN.AX -4.01%

NTI.AX 1.43%

NXS.AX -6.38%

ONE.AX -3.75%

PCK.AX 3.70%

PME.AX -5.31%

PNV.AX -4.90%

PSQ.AX -0.79%

REG.AX -3.21%

RHC.AX -1.60%

RHY.AX -3.23%

RSH.AX 13.04%

SHL.AX -2.43%

SIG.AX -2.35%

SNZ.AX 0.81%

TTB.AX 0.00%

UBI.AX 0.00%

VHT.AX 0.44%

VTI.AX 0.00%

Correlación (AI algo v.1.1b): Undervalued: 4.28% $0.0501 paired level. (El Algoritmo Rastrea Los Cambios De Las Acciones Más Correlacionadas En Tiempo Real Y Proporciona Una Actualización Instantánea)

Emerald Clinics Ltd Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Emerald Clinics Ltd Finanzas

Annual	2023
Ingresos:	$1.59M
Beneficio Bruto:	$-3.32M (-208.56 %)
EPS:	$-0.0177

FY	2023
Ingresos:	$1.59M
Beneficio Bruto:	$-3.32M (-208.56 %)
EPS:	$-0.0177

FY	2022
Ingresos:	$1.82M
Beneficio Bruto:	$-4.41M (-242.22 %)
EPS:	$-0.0273

FY	2021
Ingresos:	$1.21M
Beneficio Bruto:	$-1.06M (-87.51 %)
EPS:	$-0.0284

Financial Reports:

No articles found.

Emerald Clinics Ltd Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Emerald Clinics Ltd

Emyria Limited, a clinical-stage biotech company, engages in the development of treatments for unmet medical needs. The company develops cannabinoid-based medicines, as well as MDMA drug discovery program. Its drug development program includes EMD-RX5 for treatment of psychological distress and irritable bowel syndrome; and EMD-RX7 for multiple medical conditions. The company was formerly known as Emerald Clinics Limited and changed its name to Emyria Limited in September 2020. Emyria Limited was founded in 2018 and is headquartered in Leederville, Australia.